Europe excels in fundamental research, yet too few discoveries reach the market. Many promising projects stall in the “Valley of Death,” where resources, incentives, and support for technology maturation are limited. While spin-offs attract significant attention, they are not always the right path, especially within Europe’s fragmented and under-resourced innovation landscape.
This webinar series showcases practical private, public, and hybrid models that help biomedical projects overcome these hurdles and move more effectively toward commercialisation.
In the fourth session of our series, Industry open innovation programs for collaboration with academia, Jiri Keirsse, Head of Innovation Strategy & Public Private Partnerships, and Toshal Patel, Head of Scouting and Partnering, from UCB will discuss the opportunities and challenges for academia-industry co-development in Europe, with a focus on the role of KTOs and the expectations from industry on that process.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
I strongly recommend the course, even if you are not going to set-up an office but you are part of the team that wants to change or improve how technology transfer is done at your institution.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
ASTP has excellent courses to immerse yourself into the world of tech transfer.
Qing Cai
Vrije Universiteit Brussel, Belgium
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
Most relevant, interesting and practical training I have ever had, very interactive an multi-disciplinary. It makes an IMPACT.
Edith van Lishout
KU Leuven, Belgium
Working and Learning with old and new friends – best way to do it!
Sara Matt-Leubner
University of Innsbruck, Austria
Join our newsletter and get the latest news